Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04826679 |
|---|---|
| Brief Title: | Neoadjuvant Camrelizumab in Combination With Cisplatin and Nab-paclitaxel in Resectable HNSCC |
| First Submitted : | March 30, 2021 |
| First Submitted that Met QC Criteria : | March 30, 2021 |
| First Posted : | April 1, 2021 |
| Last Update Submitted that Met QC Criteria : | March 30, 2021 |
| Last Update Posted : | April 1, 2021 |